- Report
- January 2024
- 130 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2024
- 184 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- November 2023
- 120 Pages
Asia Pacific
From €3662EUR$4,000USD£3,112GBP
- Report
- May 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- May 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- May 2024
- 200 Pages
Global
From €3799EUR$4,150USD£3,229GBP
- Report
- October 2023
- 145 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- August 2023
- 145 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- July 2023
- 145 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- December 2023
- 140 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- January 2023
- 154 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- April 2022
- 120 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- July 2021
- 112 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- March 2023
- 211 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- January 2024
- 95 Pages
Middle East, Africa
From €3158EUR$3,450USD£2,684GBP
- Report
- December 2023
- 150 Pages
Global
From €4074EUR$4,450USD£3,462GBP
From €3158EUR$3,450USD£2,684GBP
- Report
- July 2023
- 148 Pages
Europe
From €3158EUR$3,450USD£2,684GBP
- Report
- June 2023
- 146 Pages
Asia Pacific
From €3158EUR$3,450USD£2,684GBP
- Report
- January 2022
- 176 Pages
Global
From €4074EUR$4,450USD£3,462GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more